Watchlist
Loading...
US Stock MarketDetailed Quotes

ACIU AC Immune

Watchlist
2.990 +0.020+0.67% Close 09/25 16:00 ET
3.160High2.960Low25.39KVolume
Post-Market
  • 5D
  • 1D
  • 1W
  • 1M
  • 1Q
  • 1Y

About AC Immune Company

AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.

Revenue Breakdown

Business Unit:CHF
12/31/2022
Stock NameRevenueRatio
Single Segment3.94M100.00%

Comments

Read more
Paper Trade Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Claim up to $1 million virtual fund, join moomoo paper trading today! Claim Now >